Publication Date
1-1-2022
Journal
Frontiers in Human Neuroscience
DOI
10.3389/fnhum.2022.1084782
PMID
36819295
PMCID
PMC9933515
PubMedCentral® Posted Date
1-27-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
deep brain stimulation (DBS), artificial intelligence, neuroethics, Parkinson’s disease, dystonia, interventional psychiatry, adaptive DBS, epilepsy
Abstract
The deep brain stimulation (DBS) Think Tank X was held on August 17–19, 2022 in Orlando FL. The session organizers and moderators were all women with the theme women in neuromodulation. Dr. Helen Mayberg from Mt. Sinai, NY was the keynote speaker. She discussed milestones and her experiences in developing depression DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging DBS technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank X speakers was that DBS has continued to expand in scope however several indications have reached the “trough of disillusionment.” DBS for depression was considered as “re-emerging” and approaching a slope of enlightenment. DBS for depression will soon re-enter clinical trials. The group estimated that globally more than 244,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia, and Australia; cutting-edge technologies, closed loop DBS, DBS tele-health, neuroethics, lesion therapy, interventional psychiatry, and adaptive DBS.
Included in
Mental and Social Health Commons, Nervous System Diseases Commons, Neurology Commons, Neurosciences Commons